Literature DB >> 8196612

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.

J M Slingerland1, L Hengst, C H Pan, D Alexander, M R Stampfer, S I Reed.   

Abstract

Transforming growth factor beta (TGF-beta) is a potent inhibitor of epithelial cell growth. Cyclins E and A in association with Cdk2 have been shown to play a role in the G1-to-S phase transition in mammalian cells. We have studied the effects of TGF-beta-mediated growth arrest on G1/S cyclins E and A. Inhibition of cyclin A-associated kinase by TGF-beta is primarily due to a decrease in cyclin A mRNA and protein. By contrast, while TGF-beta inhibits accumulation of cyclin E mRNA, the reduction in cyclin E protein is minimal. Instead, we find that the activation of cyclin E-associated kinase that normally accompanies the G1-to-S phase transition is inhibited. A novel inhibitor of cyclin-Cdk complexes was detected in TGF-beta-treated cell lysates. Inhibition is mediated by a heat-stable protein that targets both Cdk2 and Cdc2 kinases. In G0-arrested cells, a similar inhibitor of Cdk2 kinase was detected. These data suggest the existence of an inhibitor of cyclin-dependent kinases induced under different conditions to mediate antiproliferative responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196612      PMCID: PMC358736          DOI: 10.1128/mcb.14.6.3683-3694.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  119 in total

1.  Purification of MPF from starfish: identification as the H1 histone kinase p34cdc2 and a possible mechanism for its periodic activation.

Authors:  J C Labbe; A Picard; G Peaucellier; J C Cavadore; P Nurse; M Doree
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

2.  Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2.

Authors:  J Pines; T Hunter
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

3.  DAF1, a mutant gene affecting size control, pheromone arrest, and cell cycle kinetics of Saccharomyces cerevisiae.

Authors:  F R Cross
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

4.  A family of cyclin homologs that control the G1 phase in yeast.

Authors:  J A Hadwiger; C Wittenberg; H E Richardson; M de Barros Lopes; S I Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Effects of transforming growth factor beta on growth of human mammary epithelial cells in culture.

Authors:  M Hosobuchi; M R Stampfer
Journal:  In Vitro Cell Dev Biol       Date:  1989-08

Review 6.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

7.  The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells.

Authors:  K Riabowol; G Draetta; L Brizuela; D Vandre; D Beach
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

8.  The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis.

Authors:  W G Dunphy; L Brizuela; D Beach; J Newport
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

9.  Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+.

Authors:  J Gautier; C Norbury; M Lohka; P Nurse; J Maller
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

10.  The WHI1+ gene of Saccharomyces cerevisiae tethers cell division to cell size and is a cyclin homolog.

Authors:  R Nash; G Tokiwa; S Anand; K Erickson; A B Futcher
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  80 in total

1.  Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity.

Authors:  M Tsubari; J Taipale; E Tiihonen; J Keski-Oja; M Laiho
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 2.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

3.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

4.  p27Kip1 inhibits the cell cycle through non-canonical G1/S phase-specific gatekeeper mechanism.

Authors:  Savitha S Sharma; Le Ma; W Jackson Pledger
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.

Authors:  L Pignataro; G Sambataro; D Pagani; G Pruneri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

6.  Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cip1.

Authors:  R D Beauchamp; H M Sheng; J Y Shao; E A Thompson; T C Ko
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

7.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

8.  Spy1 interacts with p27Kip1 to allow G1/S progression.

Authors:  Lisa A Porter; Monica Kong-Beltran; Daniel J Donoghue
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

9.  TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF.

Authors:  Sang Soo Kim; Kirti Shetty; Varalakshmi Katuri; Krit Kitisin; Hye Jung Baek; Yi Tang; Blair Marshall; Lynt Johnson; Bibhuti Mishra; Lopa Mishra
Journal:  Biochem Biophys Res Commun       Date:  2006-04-19       Impact factor: 3.575

Review 10.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.